CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system
about
MGMT, GATA6, CD81, DR4, and CASP8 gene promoter methylation in glioblastomaCharacterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81.Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cellsDynamic regulation of a GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Galpha q/11 associationCD81 promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expressionTetraspanin CD81 provides a costimulatory signal resulting in increased human immunodeficiency virus type 1 gene expression in primary CD4+ T lymphocytes through NF-kappaB, NFAT, and AP-1 transduction pathwaysIdentification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2.Structure-function analysis of hepatitis C virus envelope-CD81 bindingHepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNRStructural basis of ligand interactions of the large extracellular domain of tetraspanin CD81Specific tetraspanin functionsDHHC2 affects palmitoylation, stability, and functions of tetraspanins CD9 and CD151Potential cellular receptors involved in hepatitis C virus entry into cellsHuman CD81 directly enhances Th1 and Th2 cell activation, but preferentially induces proliferation of Th2 cells upon long-term stimulationDifferential expression of novel potential regulators in hematopoietic stem cells.Tetraspanins as therapeutic targets in hematological malignancy: a concise reviewRole of SNX16 in the dynamics of tubulo-cisternal membrane domains of late endosomesCharacterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptorCell fusion activity of hepatitis C virus envelope proteinsHuman monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopesFunctional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoproteinBinding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infectionEvaluation of hepatitis C virus glycoprotein E2 for vaccine design: an endoplasmic reticulum-retained recombinant protein is superior to secreted recombinant protein and DNA-based vaccine candidates.Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein.Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells.Robust hepatitis C virus infection in vitro.Tetraspanins in viral infections: a fundamental role in viral biology?Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.Identification of the hepatitis C virus E2 glycoprotein binding site on the large extracellular loop of CD81Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily.CD81 extracellular domain 3D structure: insight into the tetraspanin superfamily structural motifs.Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle EntryPrimary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infectionIdentification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 BindingDiverse CD81 Proteins Support Hepatitis C Virus InfectionAltered expression of the tetraspanin CD81 on B and T lymphocytes during HIV-1 infectionCD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus InfectionPeripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection
P2860
Q21261286-16EE81F8-8CAB-4336-B36E-C81B7531CAA7Q22010245-F060E7F6-4021-4290-9152-3E26CC6AF0CCQ24302000-37111875-D907-469B-8D47-439444C0FCAAQ24314711-9D263A7D-370A-47D6-BEFC-055BA708B57CQ24317017-19CB7DC2-91D2-452F-B485-4FEF189AB1B8Q24519068-8302ACF0-6A8A-4851-B0E0-BA111DA0A88AQ24524809-CCB52B65-FA63-41F9-BE2D-AE4F2B9D53FFQ24525189-A8710216-664D-41A5-A190-904B88FA910FQ24551041-2DAD27F1-7B14-4C21-B3C5-F2FE0C7BF098Q24598370-10A5B444-D4CD-4E4C-AF80-446A67523410Q24652356-95C4C32C-553A-4C4C-80BD-C510383E1302Q24653644-70117A55-A4AF-4E9C-A09C-BF093F8EF717Q24795289-7F5457C8-1960-419D-8F57-F960DAF1B85AQ24805311-A8C86476-6473-46D3-B283-4241A52AED6DQ24811837-1703E6F1-DECD-47DB-8F76-436321ECABE8Q27002353-1EDA36B7-7982-467A-86BD-B9B0E5B0DD2BQ27333789-78869D59-4250-48B5-9AC0-546374CF31E5Q27469307-D6A07EDE-44A4-4AA9-8F09-792112885FF4Q27469594-E184B787-65E5-4FAF-8235-20708E618B57Q27469599-2FC7693D-E0B1-44EC-AC38-2474E871452EQ27469621-830C87DE-9E4B-48D1-B422-218CB292C747Q27469669-91BCEBE8-1820-4F20-9E34-C89319339268Q27469682-207393B0-52F3-4C3A-B66B-CBB214BAB9EEQ27469721-46D8E99D-73D2-4723-8F48-0B95D625BCA8Q27469843-B883CA2B-DB66-4C55-B3A9-086B10EABDDDQ27470013-E4A9F228-4C8D-4DB6-B827-351537D9ECECQ27470936-A459579A-A924-4755-8677-44E55B4BFFE9Q27472672-BF01E9E0-183D-4C75-9FF7-8B3704B82B6AQ27472760-ED95E0B4-DA8E-4F47-B78A-662E11CDC62BQ27472837-E3BD2172-01B5-49CD-B93A-F0818BCD8D53Q27472909-77C4A6A6-E0E2-46FD-957B-786C5F7267D1Q27472918-1C6B8BFD-F8B0-47AE-9730-935A5B9C7552Q27473055-D0A77509-BD39-442B-9AE8-60C0D1F0D23EQ27473222-1C900B6C-28FC-439D-BFB1-4AF02081B7AAQ27473382-C5CC00DA-8A78-4A70-B095-3863DBCFBC23Q27477468-4A429097-5754-44BD-B9FF-BE6C006D23A6Q27477625-926D12E3-8F37-4C4D-A807-E824B739FEDAQ27478138-74E44C86-9E64-4128-998F-E9EE8ACA526FQ27480351-4EBD3E39-E187-4ED7-8A4B-F6BE48A597D8Q27480668-80BAE76C-331A-4ACC-92BA-33071EAB89AB
P2860
CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system
description
1998 nî lūn-bûn
@nan
1998 թուականին հրատարակուած գիտական յօդուած
@hyw
1998 թվականին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@ast
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@en
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@nl
type
label
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@ast
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@en
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@nl
prefLabel
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@ast
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@en
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@nl
P2093
P3181
P1476
CD81 (TAPA-1): a molecule invo ...... adhesion in the immune system
@en
P2093
P304
P3181
P356
10.1146/ANNUREV.IMMUNOL.16.1.89
P407
P577
1998-01-01T00:00:00Z